In addition, the authors found a highly significant and clinically relevant decline in FC during therapy with ETI, but there was no association between FC changes and changes in the therein-assessed GI symptoms [ 63 ].
1
—
—
In addition, the authors found a highly significant and clinically relevant decline in FC during therapy with ETI, but there was no association between FC changes and changes in the therein-assessed GI symptoms [ 63 ].